fda cder regulatory science: patient-focused drug development
Published 7 years ago • 4.7K plays • Length 3:41Download video MP4
Download video MP3
Similar videos
-
3:44
fda cder regulatory science: the importance of partnership and consortia
-
1:11
about fda’s regulatory science program
-
3:56
fda cder regulatory science: real world evidence
-
3:01
fda cder regulatory science: improving drug review with data standards
-
5:06
what is regulatory science? (video-full version)
-
0:59
patient focused drug development and the fda
-
56:31
cmc considerations for biotechnology product development: a regulatory perspective
-
1:56:15
understanding fda inspections and data
-
1:31:06
the fda drug development process: glp, gmp and gcp regulations
-
2:30
how regulatory science benefits patients
-
2:34:13
public webinar: patient-focused drug development draft guidance 3
-
1:59:38
public webinar: patient-focused drug development draft guidance 4
-
35:58
uncovering the fda: drug development
-
13:54
presentation from shaavhree buckman-garner, director, office of translational sciences, cder, fda
-
3:31
division of applied regulatory science in fda’s center for drug evaluation and research
-
10:49
01 regulatory science at fda
-
1:36
how fda is using "organ on a chip" technology to improve drug evaluation research | researching fda
-
59:34
fda lecture: advancing the science of patient input in the regulatory settings
-
36:50
webinar: preparing for the patient-focused drug development meeting on sarcopenia
-
37:02
driving biomedical innovation by advancing regulatory science at fda
-
1:58:49
public meeting: patient-focused drug development for chronic pain (part 1)
-
2:28:46
advancing generic drug development: translating science to approval – day 1 – session 2